Study of the combination use effect of DPP-4 inhibitor and alpha-glucosidase inhibitor
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000008692
- Lead Sponsor
- Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Severe ketosis,deabetic coma or precoma,type1diabetes 2) Patients before or after operation, and those with severe infections or serious injury 3) Pregnant 4) Patients with a history of hypersensitibity to the study drug 5)Patients who use of other DPP4 inhibitor or other alpha glucosidase inhibitor 6) Patients judged by the investigator to be ineligible for some other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Alteration of HbA1c between 0 month and 3 months.
- Secondary Outcome Measures
Name Time Method post-meal 2 hours GLP-1, GIP, glucagon